Jason Beaubien

Jason Beaubien is NPR's Global Health and Development Correspondent on the Science Desk.

In this role, he reports on a range of health issues across the world. He's covered mass circumcision drives in Kenya, abortion in El Salvador, poisonous gold mines in Nigeria, drug-resistant malaria in Myanmar and tuberculosis in Tajikistan. He was part of a team of reporters at NPR that won a Peabody Award in 2015 for their extensive coverage of the West Africa Ebola outbreak. His current beat also examines development issues including why Niger has the highest birth rate in the world, can private schools serve some of the poorest kids on the planet and the links between obesity and economic growth.

Prior to becoming the Global Health and Development Correspondent in 2012, Beaubien spent four years based in Mexico City covering Mexico, Central America and the Caribbean. In that role, Beaubien filed stories on politics in Cuba, the 2010 Haitian earthquake, the FMLN victory in El Salvador, the world's richest man and Mexico's brutal drug war.

For his first multi-part series as the Mexico City correspondent, Beaubien drove the length of the U.S./Mexico border making a point to touch his toes in both oceans. The stories chronicled the economic, social and political changes along the violent frontier.

In 2002, Beaubien joined NPR after volunteering to cover a coup attempt in the Ivory Coast. Over the next four years, Beaubien worked as a foreign correspondent in sub-Saharan Africa, visiting 27 countries on the continent. His reporting ranged from poverty on the world's poorest continent, the HIV in the epicenter of the epidemic, and the all-night a cappella contests in South Africa, to Afro-pop stars in Nigeria and a trial of white mercenaries in Equatorial Guinea.

During this time, he covered the famines and wars of Africa, as well as the inspiring preachers and Nobel laureates. Beaubien was one of the first journalists to report on the huge exodus of people out of Sudan's Darfur region into Chad, as villagers fled some of the initial attacks by the Janjawid. He reported extensively on the steady deterioration of Zimbabwe and still has a collection of worthless Zimbabwean currency.

In 2006, Beaubien was awarded a Knight-Wallace fellowship at the University of Michigan to study the relationship between the developed and the developing world.

Beaubien grew up in Maine, started his radio career as an intern at NPR Member Station KQED in San Francisco and worked at WBUR in Boston before joining NPR.

Across a swath of northern Nigeria, a humanitarian catastrophe is unfolding, as lead from illegal gold mines sickens thousands of children.

More than 400 kids have died, and many more have been mentally stunted for life.

Doctors Without Borders, which has set up clinics to treat the children, is calling it one of the worst cases of environmental lead poisoning in recent history.

If you want to witness the health consequences of unsafe gold mining in northwestern Nigeria, the first thing you have to do is get to the mines

There's a crisis of severe lead poisoning near the mines that's killed hundreds of children and made thousands more sick.

A large children's hospital in Durban, South Africa, is being rebuilt two decades after it closed owing to apartheid. It opened in 1931 as a facility for all races, but racial tensions in the 1980s forced its closure.

Now with Durban and the surrounding province of KwaZulu-Natal extremely hard hit by AIDS and tuberculosis, local leaders are hopeful they can begin reopening the hospital early in 2013.

In the U.S., the pap smear has become a routine part of women's health care, and it's dramatically reduced cervical cancer deaths. But in Africa and other impoverished regions, few women get pap smears because the countries lack the laboratories and other resources necessary to offer them.

Cases of drug-resistant tuberculosis are increasing around the globe, and at a faster rate than previously thought. And if that weren't enough, TB is quickly building resistance to more and more of the drugs commonly used to fight it.

The troubling picture emerged in a study just published in The Lancet.

The province of KwaZulu-Natal has emerged as the epicenter of South Africa's HIV epidemic. South Africa already has more people infected with HIV than any other country in the world, but parts of KwaZulu-Natal have HIV rates that are more than twice the national average.

Now in addition to HIV and AIDS, the province is also dealing with a major tuberculosis epidemic.

In the northeastern part of KwaZulu-Natal, dusty dirt tracks wind through pastures and fields of sugar cane. The hillsides are dotted with small huts made of cinder blocks and field stones.

The statistics on HIV and AIDS in South Africa are daunting.

In a country of 50 million people, more than 5.5 million people are living with HIV and almost 2 million people are on HIV drug treatment. Each year, roughly 300,000 more South Africans are infected with HIV, and half a million come down with tuberculosis.

Across South Africa there's a push to get more people tested for HIV.

Nationwide, roughly 18 percent of adults are infected with the virus, but many of them don't know it. And that information gap enables the spread of HIV.

In a rural part of the province of KwaZulu-Natal, Doctors Without Borders is setting up mobile testing centers in tents. Teams are also going door to door offering HIV tests on the spot.

With the largest HIV epidemic in the world, no nation has been more affected by HIV and AIDS than South Africa, but the country has also had one of the most conflicted responses to the epidemic.

A decade ago, as the virus was spreading rapidly, then-President Thabo Mbeki was questioning the link between HIV and AIDS. His health minister was advocating the use of beetroot, garlic and lemon juice to treat it.

Now, years later, South Africa is trying to make up for lost time. The nation is attempting to put in place a cutting-edge HIV treatment and prevention program.

Brazil's HIV/AIDS program — which has been praised as a model for developing nations — is now under strain.

When HIV first emerged in the 1980s, Brazil responded quickly to the epidemic. The South American country launched large-scale safe-sex drives and gave away millions of condoms. It offered free treatment to anyone who was infected. The Brazilian government took on international pharmaceutical companies and even broke patents to cut medication costs.

The news that the U.S. Food and Drug Administration this week approved the use of Truvada, an AIDS drug, to prevent infections in people who are HIV-negative is being greeted with skepticism, derision and even worry by some doctors in South Africa.

As the 19th International AIDS Conference prepares to open this weekend in Washington, one of the catch phrases swirling around the AIDS community is "treatment as prevention."

Researchers, clinicians and HIV policy experts are hailing treatment that helps prevent more infections as a possible way to end the pandemic.

Yesterday the Food and Drug Administration gave the first green light on a drug to prevent HIV transmission.

Many experts say the drug will help hasten the end of the AIDS pandemic. But experts in Brazil say the drug alone isn't the answer.

One of the drug trials the FDA considered was done at the Oswaldo Cruz Foundation Research Institute, also known as Fiocruz, in Rio de Janeiro.

The southern African nation of Botswana is grappling with a relatively new problem in the evolving AIDS pandemic: It now has a large group of HIV-positive adolescents.

The teenagers were infected at birth before Botswana managed to almost wipe out mother-to-child transmission of the virus. These children have survived because of a public health system that provides nearly universal access to powerful anti-AIDS drugs.

The southern African nation of Botswana has one of the highest rates of HIV in the world. Nearly 25 percent of all adults in the country are infected with the virus. Only the nearby kingdom of Swaziland has a higher rate.

But Botswana is also remarkable for its response to the epidemic. It has one of the most comprehensive and effective HIV treatment programs in Africa. Transmission of HIV from infected mothers to their fetuses and newborn babies has been brought down to just 4 percent.